Nicholas Investments Partners »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.2M 2.7M 1.19

More positions owned by Nicholas Investments Partners

Bwx Technologies (BWXT)
Ftai Aviation SHS (FTAI)
Embraer Sponsored Ads (ERJ)
Evercore Class A (EVR)
MGIC Investment (MTG)
Rev (REVG)
Monolithic Power Systems (MPWR)
Microsoft Corporation (MSFT)
Tfii Cn (TFII)
Transmedics Group (TMDX)
Western Alliance Bancorporation (WAL)
NVIDIA Corporation (NVDA)
Tanger Factory Outlet Centers (SKT)
Exxon Mobil Corporation (XOM)
Appfolio Com Cl A (APPF)

View all positions for Nicholas Investments Partners

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1